Clinical Research Directory
Browse clinical research sites, groups, and studies.
Modulatory Effects of Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic Nephropathy
Sponsor: University of Lahore
Summary
This 12-week randomized controlled trial evaluated the effects of resveratrol supplementation with and without a low glycemic index (LGI) diet in obese patients with diabetic nephropathy. Resveratrol, particularly at the higher dose combined with an LGI diet, significantly improved anthropometric, hepatic, renal, and biochemical parameters, including BMI, liver enzymes, BUN, UPCR, serum uric acid, phosphorus, and albumin levels. These findings suggest that resveratrol may serve as an effective nutraceutical adjunct to dietary modification for improving renal and metabolic health in diabetic nephropathy patients.
Official title: Resveratrol Supplement Along With and Without Low Glycemic Index Diet Among Obese Patients With Diabetic Nephropathy
Key Details
Gender
All
Age Range
40 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
102
Start Date
2025-06-02
Completion Date
2025-09-07
Last Updated
2026-10-23
Healthy Volunteers
Yes
Conditions
Interventions
T0 starch capsule
1 starch capsule of 300 mg along with their regular diet
T1 resveratrol capsule
1 resveratrol capsule of 300 mg per day along with a low glycemic index diet, ONCE A DAY
T2 300 mg per day along with a low glycemic index diet, TWICE A DAY
1 resveratrol capsule of 300 mg per day along with a low glycemic index diet, TWICE A DAY
Locations (1)
Sana Noreen
Lahore, Punjab Province, Pakistan